Research and Markets: Global Hyaluronic Market & Forecasts Report, 2016

DUBLIN--()--Research and Markets ( has announced the addition of the "Global Hyaluronic Market & Forecasts Report, 2016" report to their offering.

One of the main drivers in this market is the steadily growing aging population globally. Aging is one of the main causes for the high demand for HA viscosupplementation. OA affects the aging population to a great extent. Viscosupplementation helps in decreasing pain and improving function in patients with knee OA. The global demand for HA viscosupplementation is expected to increase due to the rapidly increasing aging population in different parts of the world.

The Global HA market will continue to witness a shift toward premium-priced shorter treatment regimens. Such regimes provide more convenience to the patients and result in a rise in patient acceptance of HA viscosupplementation treatment for OA. Shorter treatment regimens using premium-priced triple and single-injection products will add to the overall increase in revenues in the Global HA market during the forecast period. Patients suffering from OA in the US have widely accepted Sanofi's Synvisc-One and other single-injection products such as Monovisc and Gel-200, which have led to an increase in US shares in the Global HA market. In addition, recent approvals of TRB Chemedica's Ostenil Plus, Anika Therapeutics' Monovisc, and Sanofi's Synvisc-One for use in Europe are expected to drive the market. Further, Anika launched Monovisc in Taiwan in 2012 and Sanofi is planning to launch Synvisc-One in South Korea by 2015, which will further drive the market. Thus, shorter treatment regimens will help in sustaining the market during the forecast period.

Further, the report states that one of the major challenges faced by the market is the intense price competition. The intense price competition limits the ASP of HA viscosupplements. This in turn, brings down the ASPs of viscosupplements and the players undergo significant losses.

The key vendors dominating this market space are:

  • Ferring Pharmaceuticals Inc.
  • Fidia farmaceutici SpA
  • Sanofi SA
  • Seikagaku Corp.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology

05. Scope of the Report

06. Market Landscape

07. Geographical Segmentation

08. Key Leading Countries

09. Vendor Landscape

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Key Vendor Analysis

For more information visit


Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals